Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
07/31/202411:46AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:BBVABBVA Bilbao Vizcaya Argentaria SA
07/31/202411:46AMGlobeNewswire Inc.Voting Rights and CapitalLSE:SHELShell Plc
07/31/202411:46AMGlobeNewswire Inc.Voting Rights and CapitalEU:SHELLShell Plc
07/31/202411:46AMGlobeNewswire Inc.Voting Rights and CapitalNYSE:SHELShell plc
07/31/202411:45AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:CCitigroup Inc
07/31/202411:45AMBusiness WireMedincell’s Partner Teva Provides Update on Pivotal Clinical Phase 3 of Investigational Olanzapine Long-Acting Injectable (LAI) and UZEDY® Commercial ProgressEU:MEDCLMedincell SA
07/31/202411:45AMBusiness WireGroupe SEB: 2024 Half-year Financial Report AvailableEU:SKSEB SA
07/31/202411:45AMGlobeNewswire Inc.Cegedim: New €230 million financing arrangementEU:CGMCegedim
07/31/202411:45AMGlobeNewswire Inc.Lystek Design-Build Project Completion: Commerce Township Wastewater Treatment Plant Operating Lystek THP® with Multi-Year Agreement for Class A LysteGro® Biosolids Management
07/31/202411:45AMBusiness WireGROUPE SEB : MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2024EU:SKSEB SA
07/31/202411:45AMBusiness WireTeva, partenaire de Medincell, fait le point sur l’essai clinique pivot de phase 3 de l'Olanzapine injectable à durée d’action prolongée (LAI) et sur les progrès commerciaux de UZEDY®EU:MEDCLMedincell SA
07/31/202411:43AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
07/31/202411:43AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CNACNA Financial Corporation
07/31/202411:43AMPR Newswire (US)CSharpCorner Hosts Third Annual Software Architecture Conference
07/31/202411:42AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:TYLTyler Technologies Corp
07/31/202411:42AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:MS-PMorgan Stanley
07/31/202411:42AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BUSEFirst Busey Corporation
07/31/202411:42AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:BMOBank of Montreal
07/31/202411:41AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BML-LBank of America Corporation
07/31/202411:41AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:MS-PMorgan Stanley
07/31/202411:41AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:TYLTyler Technologies Corp
07/31/202411:41AMBusiness WireStonepeak Forms Joint Venture with American Tower to Construct a New Data Center in Denver, Colorado
07/31/202411:40AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:MS-PMorgan Stanley
07/31/202411:39AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATRCAtriCure Inc
07/31/202411:39AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:RYRoyal Bank of Canada
07/31/202411:39AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:BYByline Bancorp Inc
07/31/202411:39AMPR Newswire (US)City Of Lancaster Multi-Agency Regional Resilience Center Named "Parris Center" in Honor of Mayor R. Rex Parris and his Family
07/31/202411:38AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HTBIHomeTrust Bancshares Inc
07/31/202411:38AMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:BNSBank Nova Scotia Halifax
07/31/202411:38AMPR Newswire (Canada)Fonds signature métropole - Près de 5,6 M$ pour des projets signature pour Montréal